Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Serum amino acid profiles and their alterations in colorectal cancer.

Leichtle AB, Nuoffer JM, Ceglarek U, Kase J, Conrad T, Witzigmann H, Thiery J, Fiedler GM.

Metabolomics. 2012 Aug;8(4):643-653. Epub 2011 Sep 16.

2.

Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.

Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J.

Clin Cancer Res. 2009 Jun 1;15(11):3812-9. doi: 10.1158/1078-0432.CCR-08-2701. Epub 2009 May 26.

3.

[Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].

Ma YL, Liu WJ, Peng JY, Zhang P, Chen HQ, Qin HL.

Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Jul;12(4):386-90. Chinese.

PMID:
19598026
4.

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB.

BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.

5.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

6.

Urine Metabolite Profiling of Human Colorectal Cancer by Capillary Electrophoresis Mass Spectrometry Based on MRB.

Chen JL, Fan J, Yan LS, Guo HQ, Xiong JJ, Ren Y, Hu JD.

Gastroenterol Res Pract. 2012;2012:125890. doi: 10.1155/2012/125890. Epub 2012 Dec 2.

7.

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W.

J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.

PMID:
19678709
8.

Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.

Choi MY, Lee KM, Chung JK, Lee DS, Jeong JM, Park JG, Kim JH, Lee MC.

Ann Nucl Med. 2005 Apr;19(2):123-9.

PMID:
15909492
9.

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.

Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, Bogumil R, Büchler MW, Friess H.

Pancreas. 2007 Mar;34(2):205-14.

PMID:
17312459
10.

Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.

Perez CA, Ravindranath MH, Gupta RK, Tollenaar RA, van de Velde CJ, Wood TF, Soh D, Morton DL, Bilchik AJ.

Cancer J. 2002 Jan-Feb;8(1):55-61.

PMID:
11898807
11.

Detection of colorectal cancer using MALDI-TOF serum protein profiling.

de Noo ME, Mertens BJ, Ozalp A, Bladergroen MR, van der Werff MP, van de Velde CJ, Deelder AM, Tollenaar RA.

Eur J Cancer. 2006 May;42(8):1068-76. Epub 2006 Apr 17.

PMID:
16603345
12.
13.

Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.

Tautu C, Pee D, Dunsmore M, Prorok JJ, Alhadeff JA.

J Clin Lab Anal. 1991;5(4):247-54.

PMID:
1890538
14.

Plasma free amino acid profiling of five types of cancer patients and its application for early detection.

Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, Saruki N, Bando E, Kimura H, Imamura F, Moriyama M, Ikeda I, Chiba A, Oshita F, Imaizumi A, Yamamoto H, Miyano H, Horimoto K, Tochikubo O, Mitsushima T, Yamakado M, Okamoto N.

PLoS One. 2011;6(9):e24143. doi: 10.1371/journal.pone.0024143. Epub 2011 Sep 7.

15.

Serum biomarkers of colorectal cancer with AU and NP20 chips including a diagnosis model.

Jin X, Lin M, Zhang H, Han Y, He Y, Zhang Q, Yu S, Chen L, Dong W, Wang W, Sun W, Yin L.

Hepatogastroenterology. 2012 Jan-Feb;59(113):124-9. doi: 10.5754/hge11287.

PMID:
22260829
16.

Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.

Yepes D, Jacob A, Dauber M, Costina V, Hofheinz R, Neumaier M, Findeisen P.

Int J Oncol. 2011 Jul;39(1):145-54. doi: 10.3892/ijo.2011.1009. Epub 2011 Apr 18.

PMID:
21503574
17.

Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS.

Zheng GX, Wang CX, Qu X, Deng XM, Deng BP, Zhang J.

Exp Oncol. 2006 Dec;28(4):282-7.

PMID:
17285111
18.

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH.

Oncol Rep. 2010 Jul;24(1):57-64.

PMID:
20514444
19.

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.

Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.

PMID:
11326694
20.

Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.

Schiemann U, Günther S, Gross M, Henke G, Müller-Koch Y, König A, Muders M, Folwaczny C, Mussack T, Holinski-Feder E.

Cancer Detect Prev. 2005;29(4):356-60.

PMID:
16122885
Items per page

Supplemental Content

Write to the Help Desk